- Dr. Kimimasa Nakabayashi was born in Japan and graduated from Gunma University School of Medicine. Afterward, he studied medicine at OKLAHOMA University Hospital.
- Then, Dr. Kimimasa returned to Japan and spent as a physician of Internal Medicine, there he became a professor of Internal Medicine and also published many clinical research articles.
- Now, Dr. Kimimasa is a director of the Nakabayashi Institute for Clinical Medicine and still applied for clinical research.
Education and Academic History
- March 23, 1967: Medical School, Degree, Gunma University School of Medicine, Maebashi city, Gunma prefecture, Japan Medical Doctor (M.D.)
- July 1976: Additional academic degree, Doctor of Philosophy (Ph.D.)
- 1981-2008: Councilor of Japanese Society of Nephrology.
- 1983-2007: Councilor of Japanese Society of Clinical Immunology.
- 1988-2008: Councilor of Japanese Society of Rheumatology.
- 1992-2008: Professor of Internal Medicine, Kyorin University School of Medicine.
- 2000-2008: Councilor of Japanese Society of Internal Medicine.
- 2008: Emeritus Professor, Kyorin University.
- 2008: Established Nakabayashi Institute for Clinical medicine and its director to date.
- 1993-2008: Editorial board member of Japanese Journal of Nephrology (Clinical and Experimental Nephrology).
- 2000-2004: Editorial board member of Internal Medicine (Internal Medicine).
- 1983-2008: Member of the Research Project for the Study on the Refractory Vasculitic Syndrome Sponsored by the Ministry of Health, Labour, and Welfare of Japan.
- 1999-2008: Chief of the Division for Survey and Treatment Trial on Small- and Middle- sized Vasculitides, belonged to the Research Project for the Study on the Refractory Vasculitic Syndrome Sponsored by the Ministry of Health, Labour, and Welfare of Japan.
- 1999-2002: Member of study group for Vasculitic Syndrome supported by the Ministry of Education, Science, and Sports of Japan.
- 2004-2006: Member of Working Group for the Revision of Lupus Nephritis belonging to International Society of Nephrology.
- Nakabayashi K, Kamiya Y, Nagasawa T. Aortitis syndrome associated with positive perinuclear antineutrophil cytoplasmic antibody; report of three cases. Int J Cardiol. 2000; 75: S89-94; discussion S95-97.
- Matsuzawa N, Nakabayashi K, Nagasawa T, Nakamoto Y. Nephrotic IgA nephropathy associated with disseminated tuberculosis. Clin Nephrol . 2002; 57: 63~68.
- Kuroda T, Yoshida Y, Kamiie J, Kovalenko P, Nameta M, Fujinaka H, Yaoita E, Endo T, Ishizuka S, Nakabayashi K, Yamada A, Nagasawa T, Yamamoto T. Expression of MMP-9 in mesangial cells and its changes in anti-GBM glomerulonephritis in WKY-rats. Clin Exp Nephrol. 2004; 8: 206~215.
- Kimura R, Matsuzawa N, Arimura Y, Soejima A, Nakabayashi K, Yamada A. Azurocidin-specific-ANCA-related idiopathic necrotizing crescentic glomerulonephritis. Am J Kidney Dis. 2004; 43: 7~10.
- Sekiuchi M, Nakabayashi K, Marumo T, Arimura Y, Nagasawa T, Yamada A, Fujioka Y. Concurrent occurrence of allergic granulomatous angiitis and temporal arteritis. Mod Rheumatol. 2005; 15: 126-129.
- Hayakawa S, Nakabayashi K, Karube M, Arimura Y, Soejima A, Yamada A, Fujioka Y. Tubulointerstitial immune complex nephritis in a patient with systemic lupus erythematosus: role of peritubular capillaritis with immune complex deposits in the pathogenesis of the tubulointerstitial nephritis. Clin Exp Nephrol. 2006; 10: 145-151.
- Endo T, Nakabayashi K, Sekiuchi M, Kuroda T, Soejima A, Yamada A. Matrix metalloproteinase-2, matrix metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in the peripheral blood of patients with various glomerular diseases and their implication in pathogenetic lesions: study based on an enzyme-linked assay and immunohistochemical staining. Clin Exp Med. 2006; 10: 253-256.
- Karube M, Nakabayashi K, Fujioka Y, Yoshihara K, Yamada A, Matsunaga A, Saito T. Lipoprotein glomerulopathy-like disease in a patient with type III hyperlipoproteinemia due to apolipoprotein E2 (Arg158 Cys)/3 heterozygosity. Clin Exp Nephrol. 2007; 11: 174- 179.
- Sato J, Kawakami T, Nakabayashi K, Fukuoka K, Hirano K, Terado Y, Yokoyama K, Ohtsuka T, Ohkura Y, Fujioka Y, Kurata A. Multiple aortic aneurysms complicated by a rupture in the systemic Lupus erythematosus. Pathology-research and practice. 2008; 204: 845-850.
- Kimimasa Nakabayashi, Ayumi Sumiishi, Katuko Sano, Yasunori Fujioka, Akira Yamada, Miho Karube, Hitoshi Koji, Yoshihiro Arimura, Toshihiko Nagasawa. Tubulointerstitial nephritis without glomerular lesions in three patients with myeloperoxidase (MPO)-ANCA associated vasculitis. Clin Exp Nephrol. 2009; 13: 605-613.
- Kimimasa Nakabayashi, Yoshihiro Arimura, Ken Yoshihara, Toshihiro Fukuoka, Miho Karube, Tunee Yamato, Hitoshi Koji, Noriko Ikegaya, Takako Ohtuka, Sohko Kawashima, Miyako Sudo, Akira Yamada. Classification of clinical subtypes, patient survival, kidney prognosis, and relapse in patients with MPO-ANCA associated vasculitis: A single-center experience. Mod Rheumatol. 2009; 19: 420-426.
- Kimimasa Nakabayashi, Yasunori Fujioka, Toshihiko Nagasawa, Tsuneo Kimura, Kaoruko Kojima, Yoshihiro Arimura, Akira Yamada. Dual myeloperoxidase-antineutrophil cytoplasmic antibody- and antiglomerular basement membrane antibody-positive cases associated with prior pulmonary fibrosis: a report of four cases. Clin Exp Nephrol. 2011; 15: 226-234
- Kimimasa Nakabayashi, Yasunori Fujioka, Yoshihiro Arimura, Toshihito Fukuoka, Tomohumi Marumo, Michiru Umino, Yasushi Kamiya, Takahiro Okai, Shigeru Tsurumaki, Toshihiko Nagasawa , Akira Yamada. Anti-glomerular basement membrane (anti-GBM) disease accompanied by vasculitis that was not positive for antineutrophil cytoplasmic antibodies to myeloperoxidase and proteinase 3: a report of two cases and the incidence of anti-GBM disease at one institution. Clin Exp Nephrol. 2011; 15: 504-513.
- Makiho Sekiuchi, Akihiko Kudo, Kimimasa Nakabayashi, Masami Kanai-Azuma, Yoshihiro Akimoto, Hayato Kawakami, Akira Yamada. Expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of matrix metalloproteinases 2 and 1 in the glomeruli of human glomerular diseases: the results of studies using immunofluorescence, in situ hybridization, and immunoelectron microscopy. Clin Exp Nephrol. 2012; 16: 863-874.
- Hitoshi Koji, Takuya Yazawa, Kimimasa Nakabayashi, Yasunori Fujioka, Hiroshi Kamma, Akira Yamada. CD8-positive T-cell lymphoproliferative disorder associated with Epstein-Barr virus-infected B-cells in a rheumatoid arthritis patient under methotrexate treatment. Mod Rheumatol. 2016; 26: 271-275.
- Kimimasa Nakabayashi, Masachika Fujiwara, Masato Nose, Ryota Matsuki, Yasuo Ohkura, Hiroshi Kamma, Masanori Sugiyama, Ayumi Sumiishi. Perforated M eckel’s Diverticulitis and an Ileal Ulcer in Rheumatoid Arthritis: The Pathogenic Role of Arterial Thrombosis in these Lesions. THE KITAKANTO MEDICAL JOURNAL. 2015; 65: 61-68.
- Kimimasa Nakabayashi. Anti-Glomerular Basement Membrane Glomerulonephritis and Vasculitis: The Existence of Two Different Pathogenetic Mechanisms for the Formation of Crescentic Glomerulonephritis with or without Vasculitis and the Association with Antineutrophil Cytoplasmic Antibody. J Kidney. 2016; 2: 1-2.
- Kimimasa Nakabayashi, Kazuhito Fukuoka, Ayumi Sumiishi, Katuko Sano, Masato Nose, Kunimasa Yan, Akihiko Kudo, Sachie Matsubara, Yoshihiro Arimura. The Appearance of In vivo ANA Positivity after a Period of 17 years in a Patient with Lupus Nephritis who had Received both Methylprednisolone and Cyclophosphamide Pulse Therapy. J Kidney. 2018; 4: 1-5.
- Yuka Nishibata, Sakiko Masuda, Daigo Nakazawa, Satoshi Tanaka, Utano Tomaru, Mandkhai Nergui, Jia Xiao-yu, Zhao Cui, Ming-hui Zhao, Kimimasa Nakabayashi, Akihiro Ishizu. Epitope recognized by anti-glomerular basement membrane (GBM) antibody in a patient with repeated relapse of anti-GBM disease. Experimental and Molecular Pathology 2019; 107: 165-170.
- Aya Mori, Kimimasa Nakabayashi, Hiroko Konishi, Ippei Doi, Rie Tagaya, Aya Nakase, Masayoshi Iwakami. Central Retinal Arterial and Venous Occlusion in a Patient with Systemic Sclerosis and a Review of the Related Literature. American Journal of Internal Medicine 2021; 9(4): 214-218.
